Not So Different: A Podcast From The Center For Biosimilars

Show notes Written version of the roundup Phase 3 denosumab trial results Alvotech’s pharmacokinetics trial for denosumab Poster from the American Society of Clinical Oncology’s annual meeting Phase 1 pertuzumab trial Rituximab studies from the European Hematology Association Congress 2022 Survey on preparing patients and providers for switching to a biosimilar